zidovudine has been researched along with Developmental Disabilities in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 4 (80.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (20.00) | 2.80 |
Authors | Studies |
---|---|
Awadu, JE; Coventry, A; Ezeamama, AE; Giordani, B; Sikorskii, A; Zalwango, S | 1 |
Arpadi, S; Chang, CJ; Dobroszycki, J; Hoberman, M; Lambert, G; Nozyce, M; St Louis, Y; Wiznia, A | 1 |
Armstrong, FD; Seidel, JF; Swales, TP | 1 |
Aronson, JE; Bakshi, S; Boland, M; Borkowsky, W; Connor, E; Hoyt, L; Krasinski, K; McSherry, G; Oleske, J; Persaud, D | 1 |
Ekert, H; Gatenby, PA; Jupe, DM; Keller, AJ; Kemp, AS; Palasanthiran, P; Smales, O; Ziegler, JB | 1 |
1 review(s) available for zidovudine and Developmental Disabilities
Article | Year |
---|---|
Pediatric HIV infection: a neuropsychological and educational challenge.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS Dementia Complex; Central Nervous System Diseases; Child; Child Behavior Disorders; Child, Preschool; Cognition Disorders; Developmental Disabilities; Female; HIV Seropositivity; Humans; Immunosuppression Therapy; Infant; Infant, Newborn; Male; Maternal-Fetal Exchange; Pregnancy; Zidovudine | 1993 |
1 trial(s) available for zidovudine and Developmental Disabilities
Article | Year |
---|---|
A 12-month study of the effects of oral zidovudine on neurodevelopmental functioning in a cohort of vertically HIV-infected inner-city children.
Topics: Black or African American; Body Height; Body Weight; CD4-Positive T-Lymphocytes; Child; Child, Preschool; Cognition Disorders; Cohort Studies; Developmental Disabilities; Female; Hispanic or Latino; HIV Infections; Humans; Infant; Leukocyte Count; Male; Neuropsychological Tests; New York City; Poverty; Psychomotor Disorders; Socioeconomic Factors; Treatment Outcome; Urban Population; Zidovudine | 1994 |
3 other study(ies) available for zidovudine and Developmental Disabilities
Article | Year |
---|---|
Developmental Disorder Probability Scores at 6-18 Years Old in Relation to In-Utero/Peripartum Antiretroviral Drug Exposure among Ugandan Children.
Topics: Adolescent; Anti-HIV Agents; Anti-Retroviral Agents; Autism Spectrum Disorder; Child; Developmental Disabilities; Female; HIV Infections; Humans; Lamivudine; Peripartum Period; Pregnancy; Pregnancy Complications, Infectious; Probability; Uganda; Zidovudine | 2022 |
Varicella does not appear to be a cofactor for human immunodeficiency virus infection in children.
Topics: CD4-Positive T-Lymphocytes; Chickenpox; Child; Child, Preschool; Developmental Disabilities; Female; HIV Infections; Humans; Longitudinal Studies; Male; Retrospective Studies; Zidovudine | 1992 |
Zidovudine (AZT) therapy in children with HIV infection: the Australian experience.
Topics: Adolescent; Child; Child, Preschool; Developmental Disabilities; Failure to Thrive; Female; HIV Infections; Humans; Infant; Male; Opportunistic Infections; Respiratory Tract Infections; Retrospective Studies; Zidovudine | 1990 |